In another study, high dose administration of TLR9 ligand (CpG-ODN) inhibited the differentiation of FVIII specific memory B cells to antibody secreting cells (ASCs) in the presence of high concentrations of FVIII in hemophilia A mice (74). Here, TLR9 is linked to hemophilia A.